Bayer Aktiengesellschaft (BAYZF)
OTCMKTS
· Delayed Price · Currency is USD
42.14
-1.73 (-3.94%)
Mar 6, 2026, 10:08 AM EST
Bayer Aktiengesellschaft Revenue
In the year 2025, Bayer Aktiengesellschaft had annual revenue of 45.58B EUR, down -2.21%. Bayer Aktiengesellschaft had revenue of 11.44B in the quarter ending December 31, 2025, a decrease of -2.48%.
Revenue
45.58B EUR
Revenue Growth
-2.21%
P/S Ratio
0.77
Revenue / Employee
514.96K EUR
Employees
88,502
Market Cap
41.46B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 45.58B | -1.03B | -2.21% |
| Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
| Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
| Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
| Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Elite Pharmaceuticals | 140.12M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 937.00K |
| Silence Therapeutics | 559.00K |
| Tian'an Technology Group | 2.12M |
| Vaxart | 148.20M |
Bayer Aktiengesellschaft News
- 4 days ago - Bayer Aktiengesellschaft (BAYRY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Bayer AG (BAYRY) Q4 2025 Earnings Call Highlights: Strong Financial Performance Amid Challenges - GuruFocus
- 5 days ago - Bayer's $7.25 billion Roundup settlement gets initial OK from Missouri judge - Reuters
- 5 days ago - Q4 2025 Bayer AG Earnings Call Transcript - GuruFocus
- 5 days ago - Bayer (BAYRY) Secures Preliminary Approval for $7.25 Billion Roundup Settlement - GuruFocus
- 5 days ago - Bayer (BAYRY) Shares Decline Amid Lower Earnings Forecast and Legal Settlements - GuruFocus
- 5 days ago - DAX Eyes Bullish Recovery After 6% Slide and Retest of Psychological 24000 Handle - Action Forex
- 5 days ago - Trade Idea: DAX eyes bullish recovery after 6% slide and retest of psychological 24000 handle - MarketPulse